| Latest Qiagen N.V. - Common Shares News Headlines | | Date | Time | Source | | | 08/04/2009 | 8:00AM | PRNUS | Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
VENLO, The Netherlands, Aug. 4 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGEN) today announced the Webcast of its second quarter 2009 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 11, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and... More...>> |
| 04/28/2009 | 9:00AM | PRNUS | Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) First Quarter 2009 Financial Results Call Set for May 5
VENLO, The Netherlands, April 28 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGEN) today announced the Webcast of its first quarter 2009 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, May 5, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland... More...>> |
| 03/10/2009 | 12:51PM | PRNUS | New Report - Prospering in a Down Market: Strategies for Life Science Suppliers
ARLINGTON, Va., March 10 /PRNewswire/ -- BioInformatics, LLC announces availability of its newest report, Prospering in a Down Market: Strategies for Life Science Suppliers. In this report, BioInformatics, LLC (http://www.gene2drug.com/), the premier research and advisory firm serving the life science market, provides... More...>> |
| 12/15/2008 | 2:35PM | PRNUS | QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
VALENCIA, Calif. and GERMANTOWN, Md., Dec. 15 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ:QGENNASDAQ:Frankfurt:NASDAQ:QIA), which has its global headquarters in the Netherlands and United States offices in five locations, brought on board its 3,000th employee this month. Company officers hailed this growth as a symbol... More...>> |
| 12/15/2008 | 2:35PM | PRNUS | QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
VALENCIA, Calif. and GERMANTOWN, Md., Dec. 15 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ:QGENNASDAQ:Frankfurt:NASDAQ:QIA), which has its global headquarters in the Netherlands and United States offices in five locations, brought on board its 3,000th employee this month. Company officers hailed this growth as a symbol... More...>> |
| 07/29/2008 | 9:00AM | PRNUS | Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
VENLO, The Netherlands, July 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGEN) today announced the Webcast of its second quarter 2008 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 5, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and... More...>> |
| 04/29/2008 | 9:00AM | PRNUS | Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
VENLO, The Netherlands, April 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGEN) today announced the Webcast of its first quarter 2008 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, May 6, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland... More...>> |
| 04/29/2008 | 7:45AM | PRNUS | Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
VENLO, Netherlands, April 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGEN) announces the following Webcast:
What: QIAGEN N.V. - First Quarter 2008 Earnings Announcement
When: Tuesday, May 6, 2008 at 9:30am EDT
Where: http://www.videonewswire.com/event.asp?id=48062
How: Live over the Internet... More...>> |
| 07/27/2007 | 1:40PM | PRNUS | HealthShares(TM) Announces Change to the HealthShares(TM) Diagnostics Index
NEW YORK, July 27 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Diagnostics Index, that effective at the opening of trading on Monday July 30, 2007... More...>> |
| 02/12/2007 | 3:31PM | PRNUS | QIAGEN Significantly Expands its Portfolio of Licenses to Real-Time PCR
Two New Licenses Added to Technology Portfolio targeting Molecular Diagnostics
VENLO, The Netherlands, February 12 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGENNASDAQ:FrankfurtNASDAQ:PrimeNASDAQ:Standard:NASDAQ:QIA), the worldwide leading provider of sample and assay technologies for research in life sciences... More...>> |
| 02/01/2007 | 4:18PM | PRNUS | Life Scientists Embrace New Media
ARLINGTON, Va., Feb. 1 /PRNewswire/ -- Life scientists rely on the Internet when conducting their research. A new study shows that they are increasingly turning to new digital information sources to find the products used in their labs. On average, respondents use four to five eMarketing channels to find information... More...>> |
| 01/29/2007 | 2:00AM | PRNUS | QIAGEN Unveils Revolutionary Sample Processing Platform
The QIAcube Creates New Dimension of Utility for any User Conducting Molecular Biology
VENLO, The Netherlands, January 29 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGENNASDAQ:FrankfurtNASDAQ:PrimeNASDAQ:Standard:NASDAQ:QIA), the worldwide leading provider of sample and assay technologies for life sciences, applied... More...>> |
| 01/08/2007 | 2:00AM | PRNUS | QIAGEN and Pathway Diagnostics Sign Agreement to Address Biomarker Development Needs in Pharma
Unique Offering Will Enhance Clinical Development and Validation of Biomarkers in Global R&D Programs and Clinical Trials
VENLO, The Netherlands, January 8 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ:QGENNASDAQ:FrankfurtNASDAQ:PrimeNASDAQ:Standard:NASDAQ:QIA), a leading provider of molecular diagnostics products and... More...>> |
| 12/05/2006 | 4:55PM | PRNUS | Market for Synthetic siRNA Shows Significant Growth Potential
ARLINGTON, Va., Dec. 5 /PRNewswire/ -- A new report from BioInformatics, LLC, "Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical & Biotech Industry," found that while the use of synthetic siRNA is still relatively new, the industrial market segment will continue strong growth over the near term. Among... More...>> |
| 09/06/2006 | 10:09AM | PRNUS | Global Market for DNA Oligos Tops $700 Million Annually
ARLINGTON, Va., Sept. 6 /PRNewswire/ -- According to the findings of a new report from BioInformatics, LLC, total spending by research scientists on synthetic DNA oligonucleotides (oligos) is over US$700 million annually. In the last decade, the demand for high quality oligonucleotides has risen with the focus on microarray... More...>> |
| 05/04/2006 | 3:35PM | PRNUS | Strong Influence of Brand Differentiation on Life Science Market Competition
ARLINGTON, Va., May 4 /PRNewswire/ -- A newly released study evaluates brand differences among 17 leading brands in the life science supply market and customer perceptions about competitors. According to consumers, Affymetrix (NASDAQ:AFFX) was considered the most differentiated brand. Life scientists cited its performance... More...>> |
| 04/04/2006 | 10:32AM | PRNUS | 2006 Life Science Industry Awards Winners
ARLINGTON, Va., April 4 /PRNewswire/ -- More than 200 top executives from companies throughout the industry and around the globe were in attendance to represent and honor those companies that have made the greatest contributions to life science technology in the past year. The Life Science Executive Exchange--an online... More...>> |
| 03/08/2006 | 8:00AM | PRNUS | 2006 Life Science Industry Awards Finalists
ARLINGTON, Va., March 8 /PRNewswire/ -- The Life Science Executive Exchange -- an online community of senior executives -- together with The Scientist (http://www.the-scientist.com/) and The Science Advisory Board (http://www.scienceboard.net/) is pleased to announce the finalists of the 2006 Life Science Industry Awards... More...>> |
| 12/05/2005 | 5:31PM | PRNUS | In the Market for Taq DNA Polymerase, the Change in Patent Status Has Not Affected Brand Preferences
ARLINGTON, Va., Dec. 5 /PRNewswire/ -- A recent study of scientists who use Taq DNA Polymerase (Taq) shows that slightly over half of the respondents would consider changing their primary supplier of Taq with the appropriate inducement(s). As the engine that fuels the polymerase chain reaction (PCR), one of the most... More...>> |
| 11/22/2005 | 2:01AM | PRNUS | QIAGEN Announces Supply Agreement to Provide Preanalytical Solutions to Osmetech Molecular Diagnostics
VENLO, The Netherlands, November 22 /PRNewswire-FirstCall/ -- QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. (NASDAQ:QGENNASDAQ:FrankfurtNASDAQ: PrimeNASDAQ:Standard:NASDAQ:QIA) and Osmetech Molecular Diagnostics., a division of Osmetech plc (London Stock Exchange: OMH), today announced that they have entered... More...>> |
|